Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin


ABSTRACT: The objective of this study is to identify the genes that are up-regulated amid proteasome dysfunction to facilitate the discovery of proteolytic pathways that are activated as a compensatory response to proteasome inhibition. Proteasome is a large multi-component proteolytic complex in the cell. It is responsible for the constitutive turn-over of many cellular proteins as well as the degradation of oxidized and/or unfolded proteins. With such a fundamental role in the cell, disruption of proteasome understandably can lead to disastrous outcome. Oxidative stress has been postulated as the driving mechanism for aging. Oxidatively modified proteins, which usually have lost their activity, require immediate removal by proteasome to maintain normal cellular function. Dysfunction of proteasome has also been linked to neuro-degenerative diseases such as Alzheimer?¢¬Ä¬ôs and Parkinson?¢¬Ä¬ôs diseases, those that are most commonly seen in aged population. There is more than one proteolytic pathway in the cell, and it has been reported that obstruction of any one of these pathways may enhance the activity of the others. Proteasomal function has been found to have decreased during aging, prompting researchers to hypothesize that failure to remove oxidized proteins may play an important role in aging. It would be interesting to determine the other proteolytic pathways that are activated after proteasome inhibition by a relatively specific inhibitor epoxomicin to help understand their roles in aging processes. Experiment Overall Design: Human embryonic kidney cells (HEK293) were untreated or treated with 1 uM epoxomicin for 1 and 6 hours. Total RNA was extracted for gene expression profiling using Affymetrix human genome U133 2.0 plus chip. A quadrupliate was prepared for each treatment. Experiment Overall Design: contributor: NHLBI Gene Expression Core Facility

ORGANISM(S): Homo sapiens

SUBMITTER: Allen HK Chang 

PROVIDER: E-GEOD-14429 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Iron regulatory protein 2 turnover through a nonproteasomal pathway.

Chang Allen H K AH   Jeong Jinsook J   Levine Rodney L RL  

The Journal of biological chemistry 20110510 27


Iron regulatory protein 2 (IRP2) controls the synthesis of many proteins involved in iron metabolism, and the level of IRP2 itself is regulated by varying the rate of its degradation. The proteasome is known to mediate degradation, with specificity conferred by an iron-sensing E3 ligase. Most studies on the degradation of IRP2 have employed cells overexpressing IRP2 and also rendered iron deficient to further increase IRP2 levels. We utilized a sensitive, quantitative assay for IRP2, which allow  ...[more]

Similar Datasets

2009-01-15 | GSE14429 | GEO
2022-08-15 | GSE156346 | GEO
2022-04-12 | GSE184820 | GEO
2018-02-16 | GSE97865 | GEO
2019-06-16 | GSE103336 | GEO
2020-07-26 | GSE153983 | GEO
2023-03-11 | PXD033854 | Pride
2010-10-08 | GSE22853 | GEO
2010-10-08 | E-GEOD-22853 | biostudies-arrayexpress
2023-03-21 | GSE206051 | GEO